Actinium Pharmaceuticals Insider Trades

ATNM

Track insider trading activity from Actinium Pharmaceuticals executives and directors. See which insiders are buying and selling ATNM stock.

Trades Last 12 Months

ATNM Price

All Insider Trades for Actinium Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Seth Sandesh Chief Executive Officer
Holding Value $214k 184,481 shares
Last Trade
Aug 18, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$207k 120,900 shares
$1.71
$1.16
O'loughlin Steve Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$408k 253,123 shares
$1.61
$1.16
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$85.5k 50,000 shares
$1.71
$1.16
Chell Jeffrey W. Director
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$294k 182,484 shares
$1.61
$1.16
Shetty Ajit Director
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$294k 182,484 shares
$1.61
$1.16
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.03k 2,500 shares
$1.61
$1.16
Holding Value $0 0 shares
Last Trade
Mar 31, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$298k 184,984 shares
$1.61
$1.16
O'loughlin Steve Chief Financial Officer
Holding Value $294k 253,123 shares
Last Trade
Dec 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.27M 253,123 shares
$5.00
$1.16
Berger Mark Stanley Chief Medical Officer
Holding Value $77.9k 67,164 shares
Last Trade
Sep 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$408k 67,164 shares
$6.07
$1.16
Ludwig Dale L. Chief Science & Tech. Officer
Holding Value $58k 50,000 shares
Last Trade
Aug 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$478k 50,000 shares
$9.55
$1.16
Kapur Anil Chief Commercial Officer
Holding Value $464k 400,000 shares
Last Trade
Jul 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.78M 400,000 shares
$6.96
$1.16
Ray Nitya G. Executive VP
Holding Value $87k 75,000 shares
Last Trade
Jul 13, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.76M 75,000 shares
$23.49
$1.16
Traversa Sergio Director
Holding Value $87k 75,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 75,000 shares
$41.70
$1.16
Cicic Dragan Chief Technology Officer
Holding Value $87k 75,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.13M 75,000 shares
$41.70
$1.16
Dave Kaushik J CEO And Interim CFO
Holding Value $290k 250,000 shares
Last Trade
Mar 14, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 250,000 shares
$41.70
$1.16
Holding Value $5.59M 4,821,226 shares
Last Trade
Aug 31, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.39M 136,853 shares
$54.00
$1.16
Holding Value $5.75M 4,952,888 shares
Last Trade
Aug 16, 2016 Sale (Open Market)Shares sold on the open market or in a private sale.
$236k 4,629 shares
$51.00
$1.16
Mazanet Rosemary Director
Holding Value $116 100 shares
Last Trade
May 15, 2013 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.9k 100 shares
$118.50
$1.16
Talley John V. CEO And President
Holding Value $0 0 shares
Last Trade
Dec 28, 2012 Sale
$1.05M 699,300 shares
$1.50
$1.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up